This announcement is a separate document:
沃森生物：关于放弃控股子公司股权转让优先购买权并签署相关协议的公告
Watson Biotech: Announcement on relinquishing priority purchase rights to transfer shares of holding subsidiaries and signing related agreements
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.